J.O. Oortweg 19
2333 CH Leiden, The Netherlands
MIMETAS is a Leiden-based microfluidics company founded in 2013. MIMETAS develops Organ-on-a-Chip technology for testing of new medicines. Its unique microfluidic technology enables testing of new medicines in high-throughput on miniaturized organ models. These models have better predictability compared to laboratory animals and conventional cell culture models. The basis under MIMETAS is comprised of a unique prototyping and production platform, a world-leading position in passive microfluidics and a unique value proposition based on Organ-on-a-Chip technology. Currently, MIMETAS offers 3D culture microfluidic plates, while validating a range of organ models to be launched soon. Ultimately, the MIMETAS platform will be made available for patients to select optimal, individualized therapies.